DORA
AI-driven tool to streamline academic paper drafting and accelerate drug discovery research.
Executive Summary
DORA, or Draft Outline Research Assistant, is an advanced AI-driven tool developed by Insilico Medicine, with support from NVIDIA. It is designed to significantly streamline and accelerate the drug discovery research process, particularly in the realm of academic writing and scientific content generation. DORA helps researchers produce coherent, structured, and well-cited papers, making the entire research workflow smoother and faster. The tool facilitates various research tasks, including disease hypothesis generation, target discovery, clinical trials analysis, and bioinformatics analysis. It achieves automated document generation by integrating multiple AI agents, enhancing the quality and productivity of pharmaceutical research. While an open-source version is available on GitHub, a SaaS version of DORA offers an even more extensive library of pre-designed templates for creating diverse scientific content.
Use Cases
- Drafting academic papers and scientific content
- Disease hypothesis generation
- Target discovery and validation
- Clinical trials analysis
- Bioinformatics analysis
Features
Visibility
- Structured Document Outlines: Generates clear and logical outlines for academic papers and scientific reports.
- Template Library: Access to a comprehensive collection of pre-designed templates for various scientific content types.
- Citation Management: Assists in producing well-cited papers by integrating relevant literature.
Intelligence
- Automated Content Generation: AI-driven generation of scientific drafts, summaries, and research content.
- Research Task Automation: Automates tasks like disease hypothesis generation, target discovery, and clinical trial analysis.
- Bioinformatics Analysis Support: Provides AI assistance for complex bioinformatics data analysis.
Technical Specifications
- Architecture
- Self-hostable open-source core plus separate SaaS offering
- Deployment
- Cloud + On-Premise
Infrastructure
- Microsoft Azure
- Microsoft Foundry
AI/ML Stack
- Generative AI
- Multi-agent AI systems
- Multi-agent LLMs
- Agentic AI
- Microsoft Foundry models
- O3 Deep Research
Integrations
- GitHub
- Microsoft Azure
- Microsoft Foundry
- PandaOmics
- Insilico Data Warehouse
- Microsoft Marketplace
Pricing
- Model
- Open-source / SaaS
- Starting Price
- Free
- Target Customer
- Mid-Market,Enterprise,SMB,Academic,Research
- Free Trial
- Yes
About Insilico Medicine
Insilico Medicine is a clinical-stage biotechnology company that leverages artificial intelligence and deep learning to accelerate drug discovery and development. The company focuses on therapeutic solutions for cancer, fibrosis, immunity, central nervous system diseases, and age-related conditions, utilizing its proprietary Pharma.AI platform to discover novel targets, design new molecules, and advance candidates into human clinical trials.
Alternatives to DORA
- DRG Fusion by Clarivate — Ignite commercial success in life sciences and healthcare with modular analytics powered by real-world data.
- Drug Creation Partnerships by Absci — Leverage Absci's AI and wet lab platform for rapid discovery of breakthrough biologics.
- Drug Discovery & Pre-clinical Development Services by Evotec — Integrated R&D programs and standalone services for accelerated drug discovery and preclinical development.
- EVA Platform by LabGenius — AI-driven platform for ultra-high-throughput protein engineering and antibody discovery.
- EVOcells by Evotec — Integrated iPSC-based platform for cell therapy discovery, development, and manufacturing.
- Evotec AI Platform by Evotec — Accelerating drug discovery and development through integrated AI-driven innovation and advanced technologies.
- Fabry Disease Program (αGal) by Relay Therapeutics — Advancing a preclinical genetic therapy for Fabry Disease.
- GB-0895 by Generate Biomedicines — Long-acting anti-TSLP antibody for severe asthma, advancing to Phase 3.